Auriga Resumes Coverage on Marvell (MRVL) at Buy; Attractive Valuation and Long Term Positioning Trumps Near/Mid Term Challenges

Go back to Auriga Resumes Coverage on Marvell (MRVL) at Buy; Attractive Valuation and Long Term Positioning Trumps Near/Mid Term Challenges